RPRX

Over the past six months, Royalty Pharma's stock has increased significantly, reaching a 52-week high of $51.54. Key events impacting the stock price include strong Q1 2026 financial results and raised guidance, capital deployment and acquisitions, dividend declarations and share buybacks, and positive clinical trial results.